Patterns of multimorbidity in older adults with multiple myeloma: An analysis of SEER-Medicare. [PDF]
Oyinbo AG +7 more
europepmc +1 more source
Cellular Identity Crisis: RD3 Loss Fuels Plasticity and Immune Silence in Progressive Neuroblastoma
Researchers discovered that therapy‐induced loss of RD3 protein in neuroblastoma triggers a dangerous shift: cancer cells become more stem‐like, invasive, and resistant to treatment while evading immune detection. RD3 loss suppresses antigen presentation and boosts immune checkpoints, creating an immune‐silent environment.
Poorvi Subramanian +7 more
wiley +1 more source
Digital marketing and the transformation of exclusivity in luxury branding
Stefan Krsmanović
openalex +2 more sources
Surface Graphitized Mesoporous Carbon Surpasses the Conductivity–Porosity Trade‐Off
Electrochemical cathodic polarization in molten CaCl2‐NaCl converts mesoporous carbon (MC) into surface‐graphitized mesoporous graphite, simultaneously increasing surface area (397–867 m2/g) and electrical conductivity (26–450 S/cm) without mass loss.
Juntian Fan +12 more
wiley +1 more source
Genome guided LAMP assay for rapid and reliable detection of Xanthomonas axonopodis pv. vasculorum. [PDF]
Marabella M +17 more
europepmc +1 more source
ZBTB21 is a transcription factor that epigenetically suppresses pyroptosis and MHC‐I antigen presentation, enabling tumor immune evasion. Genetic ablation of ZBTB21 activates pyroptotic cell death and enhances antigen presentation, recruiting CD8+ T cells to overcome immune checkpoint blockade resistance.
Lei Zhao +12 more
wiley +1 more source
Distinct Molecular and Prognostic Profiles of Left- and Right-Sided Colorectal Cancer Revealed by NGS Analysis: The Role of SMAD4 and SETD2 Mutations. [PDF]
Zhao W +9 more
europepmc +1 more source
Common bean pan-genome reveals abundant variation patterns and relationships of stress response genes and pathways. [PDF]
Wang X +9 more
europepmc +1 more source
The EMA as a potential driver of competitiveness of orphan medicines in Europe: a focus on regulatory incentives and funding opportunities. [PDF]
Gomez-Ferreria MA +2 more
europepmc +1 more source
Overcoming barriers to off-patent drug repurposing: a lifecycle-based policy solutions. [PDF]
Garcia-Diaz M, Epstein D, Espin J.
europepmc +1 more source

